Biggest News Aggregation in the World
📰 Cm Life Sciences News

Page 2 - Cm Life Sciences News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Cm Life Sciences. Real-time updates on events, politics, business and more.

Oak Street Health (NYSE:OSH) and GeneDx (NASDAQ:WGS) Financial Comparison

Oak Street Health (NYSE:OSH – Get Rating) and GeneDx (NASDAQ:WGS – Get Rating) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings and valuation. Profitability This table compares Oak Street Health and GeneDx’s net […]
United States Holdings Corp Cm Life Sciences Health Inc News Ratings Health Daily Oak Street Health

GeneDx (NASDAQ:WGS) Shares Up 3.5%

GeneDx Holdings Corp. (NASDAQ:WGS – Get Rating) shot up 3.5% during trading on Tuesday . The stock traded as high as $0.30 and last traded at $0.30. 2,943,442 shares were traded during mid-day trading, a decline of 25% from the average session volume of 3,940,957 shares. The stock had previously closed at $0.29. GeneDx Trading […]
Katherine Stueland Genedx Holdings Corp Holdings Corp Cm Life Sciences Genedx Holdings Get Rating
Source: wkrb13.com

Head-To-Head Analysis: GeneDx (NASDAQ:WGS) vs. Mitesco (OTCMKTS:MITI)

GeneDx (NASDAQ:WGS – Get Rating) and Mitesco (OTCMKTS:MITI – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, earnings, institutional ownership and dividends. Risk & Volatility GeneDx has a beta of 1.91, suggesting that […]
Cm Life Sciences Holdings Corp Mitesco Inc Get Rating Louis Park Genedx Daily
Source: wkrb13.com

Head to Head Analysis: GeneDx (NASDAQ:WGS) vs. Pear Therapeutics (NASDAQ:PEAR)

Pear Therapeutics (NASDAQ:PEAR – Get Rating) and GeneDx (NASDAQ:WGS – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, earnings, profitability, institutional ownership, dividends, analyst recommendations and valuation. Analyst Recommendations This is a summary of recent recommendations for […]
United States Holdings Corp Pear Therapeutics Inc Cm Life Sciences Pear Therapeutics Get Rating
Source: wkrb13.com

Head-To-Head Comparison: Mitesco (OTCMKTS:MITI) and GeneDx (NASDAQ:WGS)

Mitesco (OTCMKTS:MITI – Get Rating) and GeneDx (NASDAQ:WGS – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, profitability, dividends, earnings and analyst recommendations. Insider and Institutional Ownership 3.5% of Mitesco shares are owned by […]
Cm Life Sciences Mitesco Inc Holdings Corp Get Rating Louis Park Mitesco Daily
Source: wkrb13.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Recent Investment Analysts' Ratings Updates for Sema4 (SMFR)

A number of firms have modified their ratings and price targets on shares of Sema4 (NASDAQ: SMFR) recently: 6/2/2022 – Sema4 is now covered by analysts at The Goldman Sachs Group, Inc.. They set a “buy” rating and a $3.50 price target on the stock. 5/25/2022 – Sema4 was upgraded by analysts at Zacks Investment […]
Keitha Meister Asset Management Inc Securities Exchange Commission Gabelli Funds Goldman Sachs Group Inc Mirabella Financial Services

Research Analysts' Upgrades for May 24th (ACET, ASMB, CDZI, CWCO, DNLMY, DOCS, DSRLF, EDR, EME, EQRX)

Research Analysts’ upgrades for Tuesday, May 24th: Adicet Bio (NASDAQ:ACET) was upgraded by analysts at StockNews.com from a sell rating to a hold rating. Assembly Biosciences (NASDAQ:ASMB) was upgraded by analysts at StockNews.com from a sell rating to a hold rating. Cadiz (NASDAQ:CDZI) was upgraded by analysts at StockNews.com to a sell rating. Consolidated Water […]
United States United Kingdom Assembly Biosciences Trinet Group Dunelm Group Cm Life Sciences

EQRx (NASDAQ:EQRX) Upgraded to "Buy" by Zacks Investment Research

EQRx (NASDAQ:EQRX – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “buy” rating in a research report issued to clients and investors on Tuesday, Zacks.com reports. The firm presently has a $4.75 price target on the stock. Zacks Investment Research‘s price target points to a potential upside of 10.47% […]
United States Eqrx Company Profile Get Rating Zacks Investment Research Sb Management Ltd Cm Life Sciences Jefferies Financial Group

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science